Skip NavigationSkip to Content

Utilization of a beta-aminophosphotyrosyl mimetic in the design and synthesis of macrocyclic Grb2 SH2 domain-binding peptides

  1. Author:
    Lee, K.
    Zhang, M. C.
    Liu, H. P.
    Yang, D. J.
    Burke, T. R.
  2. Author Address

    NCI, Med Chem Lab, Ctr Canc Res, NIH, POB B,Bldg 376,Boyles St, Frederick, MD 21702 USA NCI, Med Chem Lab, Ctr Canc Res, NIH, Frederick, MD 21702 USA Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA Burke TR NCI, Med Chem Lab, Ctr Canc Res, NIH, POB B,Bldg 376,Boyles St, Frederick, MD 21702 USA
    1. Year: 2003
  1. Journal: Journal of Medicinal Chemistry
    1. 46
    2. 13
    3. Pages: 2621-2630
  2. Type of Article: Article
  1. Abstract:

    Grb2 SH2 domains are protein-docking modules that exert important functions in both normal and pathogenic signal transduction processes. Development of synthetic Grb2 SH2 domain binding ligands is being pursued by several groups as potential new therapies for a variety of diseases, including certain cancers. In these efforts, macrocyclization has been successfully utilized to take advantage of preferential recognition by Grb2 SH2 domains of ligands in beta-bend conformations. Recent examples of this approach include olefin- metathesis-derived macrocycles that employ ring closure at the beta-position of key pTyr-mimicking residues. In the current study, a novel phosphatase-stable beta-amino-pTyr mimetic designated "Pmp(beta)" was utilized to prepare variants of previously reported olefin-metathesis-derived macrocycles. An initial set of simplified cyclic peptides lacking key naphthyl side chain functionality was first synthesized to determine optimum ring size, with results indicating that a four-unit ning-closing segment was appropriate. On the basis of these findings, macrolactamization was undertaken with a more highly functionalized, naphthyl-containing gamma-amino acid analogue. The resulting cyclic beta-amino peptide is the first of a new class of pTyr-mimetic-containing ligands that may have utility in the development of antagonists of both Grb2 SH2 domains and other pTyr-dependent signaling systems.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel